Osteoporosis - a pediatric disease with gerontological consequences. When, whom and how to prevent it?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review is devoted to modern approaches to the prevention of osteoporosis (OP) and its consequences - fractures. Prevention of OP, as well as other chronic non-communicable diseases, is the main way to reduce the incidence rate. Despite the fact that the OP is more common in old age, disease prevention should begin in childhood and its purpose should be to build a strong skeleton, preventing or slowing the loss of bone mass. Scientific concept of prevention of OP after reaching the peak bone mass includes the concept of risk factors. The main attention in the development of primary prevention measures is paid to modifiable risk factors that can be corrected or eliminated. It focuses on the correction of behavioral risk factors such as good nutrition and exercise, especially the use of synthetic nutrients for the prevention of OP and fractures.

Full Text

Restricted Access

About the authors

I. A Skripnikova

FSBI "State Scientific Research Center for Preventive Medicine" of RMH

Email: Ira_Skrip@mail.ru
MD, Head of the Department of Prevention of Osteoporosis

References

  1. O'Neil T.W., Felsenberg D., Varlow J., Cooper C., Kanis J.A., Silman A.J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study Miner. J. Bone Miner. Res. 1996;11:1010-18.
  2. Ross P.D. Clinical consequences of vertebral fractures. Am. J. Mtd. 1997;103:30S-42S.
  3. Crans G.G. ,Silverman S.L., Genant H.K., Glass E.V., Krege J.H. Association of Severe Vertebral Fractures With reduced Quality of life. Reduction in the incidence of Severe Vertebral Fractures by Teriparatide. Arth. Rheum. 2004;50(12): 4028-34.
  4. Kanis J.A., Oden A., McCloskey E.V., Johansson H., Wahl D.A., Cooper C. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis Int. 2011; 22:2575-86.
  5. Михайлов Е.Е., Беневоленская Л.И., Аникин С.Г Частота переломов проксимального отдела бедренной кости и дистального отдела предплечья среди городского населения России. Остеопороз и остеопатии. 1999;3:2-6.
  6. Древаль А.В., Марченкова Л.А., Крюкова И.В. Частота переломов бедра и предплечья и затраты на их лечение в Московской области. Остеопороз и остеопатии. 2005;2:8-13.
  7. Kanis J.A., Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporosis Int. 2005;16:229-38.
  8. Cooper C., Gehlbach S. Identification of patient in need of antiosteoporotic treatment: who to treat today? Medicographia. 2006;1:13-9.
  9. Cooper C., Melton L.J. Epidemiology of osteoporosis. Trends Endocrinol. Metab. 1992;3:224-29.
  10. Hernandez C.J., Beaupre G.S., Carter D.R. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int. 2003;14:843-47.
  11. Ebeling P.R., Daly R.M., Kerr D.A., Kimlin M.G. An evidence-informed strategy to prevent osteoporosis in Australia. The Med. J. Austral. 2013;198:90-1.
  12. Методические рекомендации физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации (МР 2.3.1.2432.08), 2008.
  13. Boonen S., Vanderschueren D., Haentjens P., Lips P Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J. Intern. Med. 2006;258:539-52.
  14. Avenel A., Gillespie W.J., Gillespie J.D., O'Connell D.L. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst. Rev. 2009;2:CD000227.
  15. Остеопороз: Диагностика, профилактика и лечение. Клинические рекомендации / Под ред. Л.И. Беневоленской, О.М. Лесняк. М., 2008. 176 с.
  16. Barclay D. Calcium bioavailability from foods. Nutritional aspects of osteoporosis. Academic Press. 2001:85-95.
  17. Paddon-Jones D., Rasmussen B.B. Dietary protein recommendations and the prevention of sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care. 2009;12(1):86-90.
  18. Bolland M.J., Grey A., Avenell A., Gamble G.D., Reid I.R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
  19. Levis J.R., Calver J., Zhu K., Flicker L., Prince R.L. Calcium supplementation and the risk of atherosclerotic vascular disease in older women: results of 5-year RCTand 4,5-year follow-up. J. Bone Miner. Res.2011;26:35-41.
  20. Wang T.K., Bolland M.J., Van Pelt N.C., et al. Relationship between vascular calcification, calcium metabolism, bone density, and fractures. J. Bone Miner. Res. 2010;25:2777-85.
  21. Kendrick J., Targher G., Smits G., Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis.2009;205:255-60.
  22. Fiscella K., Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann. Fam. Med. 2010;8:11-8.
  23. Ensrud K.E., Ewing S.K., Fredman L., Hochberg M.C., Cauley J.A., Hillier T.A., Cummings S.R., Yaffe K., Cawthon PM. Circulation 25-Hydroxyvitamin D levels and frailty in older woman. J. Clin. Endocrinol. Metab. 2010;95:5266-73.
  24. Ensrud K.E., Blackwell T.L., Cauley J.A., Cummings S.R., Barrett-Connor E., Dam T.T., Hoffman A.R., Shikany J.M., Lane N.E., Stefanick M.L., Orwoll E.S., Cawthon P.M. Circulation 25-Hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in man study. J. Am. Geriatr. So c. 2011;59:101-6.
  25. Curhan G.C., Willett W.C., Speizer F.E. Spiegelman D., Stampfer M.J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stonesinwomen. Ann.Intern.Med. 1997;126(7): 497-504.
  26. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N. Engl. J. Med. 1993;328(12):833-38.
  27. Haya-Palazuelos J., Castelo-Branco C., Cancelo-Hidalgo M.J., Palacios S., Ciria-Recasens M., Fernandes-Pareja A., Manasanch-Dalmau J. Safety and efficacy of ossein-hydroxyapatite complex for the prevention of osteoporosis during perimenopause. A three year follow-up study. Maturitas. 2015;81(1):71.
  28. Castelo-Branco С., Davila J., Alvares L., Balasch J. Comparison of the effects of calcium carbonate and ossein-hydroxyapatite complex on back and knee pain and quality of life in osteopenic perimenopausal women. Maturitas. 2015;81:76-82.
  29. Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis - related fractures. Europ. J. Clin. Invest. 1996;26:436-42.
  30. Рекомендации Российской ассоциации по остеопорозу «Профилактика, диагностика и лечение дефицита витамина D и кальция среди взрослого населения и у пациентов с остеопорозом» / Под ред. О.М. Лесняк. М., 2016. 92 с.
  31. Chapuy M.C., Arlot M.E., Delmas P.D. Meunier P.J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. Br. Med. J. 1994;308:1081-82.
  32. Mastaglia S.R., Mautulen C.A., Parisi M.S., Oliveri B. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur. J. Clin. Nutr. 2006;60(5):681-87.
  33. Bonaiuti D., Shea B., lovine R., Negrini S., Robinson V., Kemper H.C., Wells G., Tugwell P., Cranney A. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst. Rew. 2002: CD000333.
  34. Hove T.E., Shea B., Dawson L.J., Downie F., Murray A., Ross C., Yarbour R.T., Caldwell L.M., Creed G. Cochrane Database of Syst. Rew. 2011:CD000333.
  35. Young C.M., Weeks B.K., Beck B.R. Simple, novel physical activity maintains proximal femur bone mineral density and improves muscle strength and balance in sedentary, postmenopausal women. Osteoporosis Int. 2007;18(10): 1279-387.
  36. Sinaki M. Prevention and treatment of osteoporosis. Physical Medicine and rehabilitation, edn 2. In Edited by Braddom RL. Philadelphia: W.B. Saunders Company, 2000. Р 894-912.
  37. Bonaiuti D., Arioly G., Diana G. PubMed SIMFER Rehabilitation treatment Guidelines in postmenopausal and senile osteoporois. Eur. Mrdicophis. 2005;41:314-37.
  38. Скрипникова И.А. Падения - важный фактор риска переломов: причины и способы профилактики. Consilium Medicum (женское здоровье). 2014;16(6):28-33.
  39. Michael Y.L., Whitlock E.P, Lin J.S., Fu R., O'Connor E.A., Gold R. Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2010;153:815-25.
  40. Guilera M., Fuentes M., Grifols M., et al. Does an educational leaflet improve selfreported adherence to therapy in osteoporosis? The OPTIMA study. Osteoporos Int. 2006;17(5):664-71.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies